Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03813706
Other study ID # ZhejiangU20190115
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2020
Est. completion date December 2040

Study information

Verified date July 2019
Source Zhejiang University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was completed in two stages. In the first stage, 2000 participants were enrolled according to the criteria. Following the principle of informed consent and voluntary consent of patients, the standard operation was "right or bilateral thyroidectomy + isthmus resection + right area VI lymph node dissection + left area VI lymph node dissection + lateral neck lymph node dissection". The age of participants, the size of right thyroid tumors, the invasion of the capsule and the number of lateral neck lymph node metastasis were counted to validate and improve the predictive model of lymph node posterior to the right recurrent laryngeal nerve in papillary thyroid cancer (Y=−0.029×age+0.771×tumor size+0.660×capsular invasion+1.331×right lateral lymph node metastasis−1.687, Y ≥0.16 means right recurrent laryngeal nerve posterior lymph node metastasis).

In the second stage, 2000 participants assessed by the model without posterior right recurrent laryngeal nerve metastasis were randomly divided into experimental group and control group according to the principle of informed consent and voluntary. The right recurrent laryngeal nerve posterior lymph nodes were not dissected in experimental group, while the right recurrent laryngeal nerve posterior lymph nodes were routinely dissected in control group. Through long-term follow-up and comparison of RFS and OS between the two groups, the investigators can scientifically evaluate the effectiveness of the "prediction model of lymph node posterior to right recurrent laryngeal nerve metastasis in papillary thyroid carcinoma", and seek evidence for accurate treatment of lymph node posterior to the right recurrent laryngeal nerve in thyroid papillary carcinoma.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 4000
Est. completion date December 2040
Est. primary completion date December 2040
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Phase I:

1. aged from 18 years old to 80 years old;

2. the primary treatment of patients with right or bilateral PTC;

3. patients will voluntarily enter the study after informed consent.

Phase II:

1. aged from 18 years old to 80 years old;

2. the primary treatment of patients with right or bilateral PTC predicted to have no LN-prRLN metastasis by the "prediction model of LN-prRLN";

3. patients will voluntarily enter the study after informed consent.

Exclusion Criteria:

1. patients refused to participate in the study;

2. non first operation patients;

3. other malignant tumor history;

4. distant metastasis;

5. history of neck trauma.

Study Design


Intervention

Procedure:
lymph node dissection
The right cervical central compartment VI is subdivided into right cervical central VI-1 subzone and VI-2 subzone. Right central VI-1 subzone lies anterior to the RLN bounded by the hyoid bone superiorly, the suprasternal notch inferiorly, the inner edge of the common carotid artery laterally, and the midline of the trachea medially. Right central VI-2 subzone lies posterior to the right RLN. The superior, inferior, lateral, and medial borders are the laryngeal entry points of RLN, the intersection of the RLN with the innominate artery (near the right apical pleura), the inner edge of the common carotid artery, and esophagus, respectively. The floor of right central VI-2 is the prevertebral fascia.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Zhejiang University

Outcome

Type Measure Description Time frame Safety issue
Primary Recurrence of thyroid cancer Participants will be followed from the operation to 20 year (maximum)
See also
  Status Clinical Trial Phase
Completed NCT03280719 - Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions N/A
Active, not recruiting NCT04300673 - Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients Phase 1/Phase 2
Completed NCT04260139 - Lymph Node Yield in Colon Cancer Resection Specimens
Not yet recruiting NCT03632746 - Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
Active, not recruiting NCT03776591 - Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer N/A
Recruiting NCT05078853 - Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
Recruiting NCT03715686 - To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes N/A
Recruiting NCT03280134 - A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer N/A
Recruiting NCT04117139 - The Diagnostic Value of PET/MRI in Head and Neck Cancer N/A
Recruiting NCT04882618 - Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. Phase 4
Recruiting NCT05670574 - Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors N/A
Active, not recruiting NCT04611997 - IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy Phase 3
Recruiting NCT04744506 - Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy N/A
Recruiting NCT03830242 - Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. N/A
Recruiting NCT04959604 - Lymph Node Mapping Via Flourescent Dye in Colon Cancer N/A
Active, not recruiting NCT04419935 - Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
Enrolling by invitation NCT04322331 - Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer
Recruiting NCT03868215 - Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis
Recruiting NCT04337333 - Two-in-one Covered and Uncovered Metal Stent N/A
Completed NCT04068636 - Sentinel Node in Larynx and Pharynx Cancers N/A